NIH-funded research Fellowship grant

How a brain chemical affects drug addiction and intake behavior

Official title: The role of corticotropin-releasing factor in modulating accumbal dopamine and producing escalation of drug intake

Funded at University of Washington · NIH-11220428 · Data updated 2026-11-12

This study looks at how a brain chemical called CRF affects dopamine, which is linked to feelings of pleasure, to help us understand why some people may use drugs more and more, with the hope of finding new ways to help those struggling with addiction.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startJune 1, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$45,255
NIH project number5F31DA059249-02
Project IDNIH-11220428 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of substance use disorders or those at risk of developing such disorders.

Less likely to help

Patients who do not have a history of substance use or are not at risk for addiction may not benefit from this research.

What this research studies

This research investigates how corticotropin-releasing factor (CRF) influences dopamine levels in the brain's reward center, particularly in relation to drug addiction. By studying the neural circuitry involved in substance use disorders, the project aims to understand why some individuals escalate their drug intake. The research employs animal models to explore the relationship between CRF and dopamine signaling, which could reveal new therapeutic targets for treating addiction. The findings may lead to innovative strategies for preventing or reducing drug abuse behaviors.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that help individuals struggling with drug addiction by targeting specific brain mechanisms.

How similar studies have gone: Previous research has shown promising results in understanding the role of brain chemicals in addiction, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Gordon-Fennell, Lydia — University of Washington
  • Study coordinator: Gordon-Fennell, Lydia

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.